The availability of clones of nucleic acid (NA) specific for genes of most viral and other microbiological organisms has made possible various approaches to search for such sequences in clinical materials using hybridisation techniques. Radioac Several extensive reviews'`and editorials8 on the topic have appeared. This overview will concentrate on the use of such techniques for the diagnosis of genitourinary tract infections and intrauterine infections and also outline the scope of the technology for the diagnosis ofother infectious diseases. As this field is evolving rapidly, it is to be expected that further approaches will become known in the near future. Figure 2 Preparation of a DNA probe. A restriction endonuclease fragment of interest (here: Hind IIIfragment X) is ligated ("inserted") into the unique Hind III site of a plasmid ("cloning vector"). The vector containing the insert is then transformed into E coli and amplified, leading to bacterial lysis. After purification of the plasmid its insert is liberated by Hind III digestion, isolated, labelled (here: 5' end label, for example with 32P) and denatured. It is now ready as "probe" for reaction with a complementary "target" DNA in a hybridisation reaction (figure lc). Figure 2 ). Linearisation of this construct with restriction endonucleases A or B and addition of SP6 of T7 polymerases, respectively, in the presence of a-32P-labelled and unlabelled ribo-NTPs will result in the production of multiple ssRNA transcripts of high specific radioactivity as probes. The system is very efficient, yielding up to 10 pg product from 1 pg template.
Template DNA is removed by treatment with RNase-free DNase I, and the transcripts purified by Sephadex chromatography. The SP6 and T7 ssRNA products are of opposite "sense" and can be used to differentiate between genomic DNA and mRNA templates (eg by in situ hybridisation).
Alternatively 5' end labelling with gamma-`P-ATP and T4 polynucleotide kinase is used for short DNA fragments or synthetic oligonucleotides.`8
The extent of hybridisation is monitored by autoradiography offilters or oftissue sections treated in situ. Dots from filters can also be cut out and counted in a liquid scintillation counter.
For various reasons (safety, costs, stability), nonradioactive methods of labelling probes have been developed.t61920 The most frequently used is the incorporation of biotinylated nucleotides (such as biotin-1 1-dUTP, figure 7) into probes. '6"920 Hybridised biotinylated NA is detected by an avidin- Figure 6 Labelling of DNA probes using the large fragment (Klenow) of E coli DNA polymerase I. 8 The polymerase chain reaction (PCR). The starting materialfor PCR, the "target sequence" of dsDNA is denatured by heating (typically 95°C, initially 60 Primer binding to 3' 5. provides an earlier diagnosis than growth in tissue culture (such as human cytomegalovirus, HCMV) or cultivation on cell-free substrates (mycobacteria). The technique can also be used in situ in formalinfixed tissues and exfoliated cells.
Disadvantages can be that only a limited number of microorganisms is detected in a specimen, depending on the composition of the probe; that detection of the genome of a microorganism is open to interpretation as to its activity (latent or productive infection); that there is the possibility of cross-reactivity of the probe with cellular (chromosomal and ribosomal) sequences present in the specimen; that the quantity of microorganisms in the specimen may be low and below the limit of detection by a probe (giving rise to false negative results); that there are no established external quality controls for the procedures yet; that the initial costs are high; and that 32P-or '25`-labelled probes have a relatively short shelf life, and their use requires special safety precautions.
However, most of the disadvantages mentioned may become less significant in the near future. There is work ongoing to incorporate several probes into one hybridisation assay and to develop probes which are highly cross-reactive within a group of microorganisms. 26 Probing for mRNA as opposed to genomic NA and for such mRNAs preferentially made in productive infections allows some statements to be made about the degree of replicative activity of the microorganism. 27 The problem of false-positivity of the probe ("spurious" cross-reactivity wth cellular NA sequences) is well recognised and can be minimised.'2 There are several and some very powerful procedures to amplify genomic NA before hybridisation. The polymerase chain reaction (PCR)'1" (diagrammatically shown in fig 8) amplifies specific DNA in vitro based on repeated cycles of denaturation by heat (> 90C), annealing of ON primers (at 50°C) and primer extension at 60-70'C using the heat-stable DNA polymerase of Thermus aquaticus (Taq polymerase). Twenty to thirty such cycles can result in 100,000-fold to 1 million-fold amplification of the target sequence. The procedure is so sensitive (detection of 1 target sequence in the DNA of 106 cells) that contamination can be a major problem.
The problems of quality control and relative costs of DNA probes need to be more precisely defined. 58 Great care has to be taken in the selection of the probe as wide parts of the CMV genome cross-react with human DNA.`9 With these precautions, latent or reactivated HCMV can be detected in lymphocytes and other tissues.27 Recently, the polymerase chain reaction (PCR) has been used to amplify HCMV-specific sequences; a high degree of sensitivity and concordance with viral isolation data from different sources (infected fibroblasts, peripheral leucocytes and urines) was achieved.6H uman Immunodeficiency Virus (HIV) By the end of 1989 approximately 200,000 cases of acquired immunodeficiency syndrome (AIDS) have been recorded worldwide (of whom more than half have died), and worldwide several million people are thought to be infected with HIV, the causative agent of AIDS. The virus, a member of the retroviridae family, is transmitted by blood and sexual contact, and homosexuals, intravenous drug abusers and haemophiliacs (before universal screening of blood donations in 1985) have been the major risk groups so far. The rate of heterosexual transmission is increasing at an alarming rate. The infection is diagnosed by testing for HIV-specific antibody (particle agglutination tests, ELISAs, Western blots) or by culturing the virus. Although culture is carried out in many laboratories, the method is cumbersome and needs special safety precautions.6`" Hybridisation techniques have been used to detect HIV genomes in lymphocytes6`" and nerve tissue. 67 Recently the PCR has been applied in order to detect HIV-specific sequences in lymphocytes and tissues and has done so with a high degree of sensitivity.63`' Such a test meets a special need as the HIV-specific seroconversion occurs several months or more after the initial infection70 and the virus has in some cases been transmitted by blood which was screened negative for HIV-specific antibody. 7 HBV infections are mainly transmitted sexually and by infected blood. A further major route of transmission is from carrier mother to child during birth. The inability to grow HBV led investigators to search for the presence of the HBV genome in serum and tissues. HBV possesses a genome of partially dsDNA which has been cloned and sequenced for several subtypes (for example ref 81) . Molecular probes derived from these sequences were used to show the presence of HBV DNA in serum,82 hepatocytes8`and various qther organs and peripheral leucocytes.89' Cloned DNA probes were successfully replaced by ON probes.92 93 Hybridisation techniques have shown the presence of HBV DNA in serum of HBsAg-and HBeAgpositive individuals and also in sera of some patients testing negative for these markers. The technology has also revealed the presence of HBV in nonhepatocytes including leucocytes. These findings provide very important criteria for infectivity of the individual. Furthermore, measuring HBV DNA is an important tool in evaluating treatment of chronically HBV-infected individuals, for example by interferon.9'
The delta agent (also named HDV) consists of closed circles of naked RNA which is intensely internally base-paired. Infection with HDV is only found in association (co-or superinfection) with HBV infection; HDV parasitises capsid and envelope ofHBV. The only HDV-specific expressed antigen is delta antigen which is incorporated into the capsid. Delta antigen and specific antibody can be measured. In addition, an HDV-specific RNA:RNA hybridisation procedure has been published9`which will shed more light on mechanisms of chronicity and latency.
Hepatitis C virus genome has recently been detected by PCR in the sera of patients with chronic legionella, mycobacterium, mycoplasma"35). The probes against the pathogenic gut bacteria are mainly based on reaction with toxin or virulence plasmid genes, whereas probes against the respiratory pathogens are based on sequences found in ribosomal RNA of these microorganisms. The probes are highly specific and in many cases highly convergent with the results from cultures which normally take much more time. Infections with parasitic agents (plasmodium, babesia,"16 leishmania"17) can also be diagnosed by DNA probes which are preferentially based on so-called repetitive sequences in the chromosomes or mitochondria of these parasites.
Summary and outlook Nucleic acid probes of different structure and labelled in various ways are increasingly used for the diagnosis of viral, bacterial and parasitic infections. The technology complements rather than replaces more classical diagnostic techniques (culture and serology) and has provided new insight into the pathogenesis and epidemiology of infectious diseases. Its usefulness for other purposes, such as susceptibility and resistance testing of microorganisms138 is being explored.
